SAN MATEO, Calif. & NEW YORK–(BUSINESS WIRE)–Biograph study shows AI imaging detected coronary inflammation in 43% of asymptomatic adults, which standard blood tests failed to identify.
Tag: Caristo Diagnostics
New Data at ESC Congress 2026 Validate Caristo’s FAI-Score™ Biomarker and Highlight Potential Non-Contrast Cardiac CT Opportunity
—Independent Oxford-led data showcase the value of coronary inflammation assessment in non-contrast cardiac CT, identifying risk even in patients with zero coronary calcium— —Late-breaking ORFAN-MAESTRIA data and additional investigator-led analyses highlight broader scientific…
Caristo’s Technology to be Featured in Non-Contrast CT and Late-Breaking Stroke Prediction Data at ESC 2026
Investigator-led abstracts will explore new data on FAI-Score’s prognostic value, alongside emerging applications in stroke prediction and virtual biopsy of arterial inflammation OXFORD, England and STAMFORD, Conn., Aug. 24, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in AI…
Caristo Diagnostics Expands Executive Team, Naming David Vort Chief Commercial Officer and Chris Louk Chief Financial Officer
Appointments to scale adoption of Caristo’s AI-powered cardiovascular technologies globally OXFORD, England and STAMFORD, Conn., July 23, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in AI-powered technologies for cardiovascular disease, today announced two additions to its…
Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo’s technologies, including—for the first time—an application of FAI-Score on non-contrast cardiac CT OXFORD, England and STAMFORD, Conn., July 8, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in…
Caristo Diagnostics Selected by World Economic Forum as a 2026 Technology Pioneer
Caristo’s flagship technology, CaRi-Heart, recognised for its groundbreaking ability to transform cardiovascular disease prevention and management Caristo joins a prestigious group of 100 global innovators chosen by the World Economic Forum to help solve major world challenges OXFORD,…
Caristo Diagnostics Appoints Stephen Deitsch as Chief Executive Officer
OXFORD, England and STAMFORD, Conn., April 14, 2026 /PRNewswire/ — Caristo Diagnostics, a University of Oxford spinout and a global leader in AI technology for cardiovascular disease, today announced the appointment of Board Member Stephen M. Deitsch as Chief Executive Officer (CEO),…
Medicare Finalizes Reimbursement for Caristo’s CaRi-Plaque™ Across Hospital and Office Settings
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease,…
NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance
Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology NCH cardiologists to present collaboration plans at American Heart Association 2025 Scientific Sessions on Nov. 8 NAPLES, Fla. and STAMFORD, Conn. , Nov. 5, 2025 /PRNewswire/ — Naples…
American Medical Association Published CPT Code for Caristo’s Coronary Inflammation Detection Technology
AMA assigns CPT codes 0992T and 0993T to Caristo’s CaRi-Heart® AI-powered analysis of perivascular fat and cardiovascular risk, which are included in the 2026 CPT® Codebook New CPT codes mark a major step toward making CaRi-Heart technology available in everyday clinical care in the U.S….
Recent
Esperto Medical Awarded Grant by the Translational Research Institute for Space Health (TRISH) to Advance Noninvasive Monitoring Technology for Spaceflight
AQUAPASS REFORM-HF Pivotal Trial Meets Primary Endpoint, Demonstrating Significant Fluid Removal in Heart Failure Patients
Orchestra BioMed Announces Proposed Public Offering
Popular
- No commented posts yet